Top Markets
#1 Helium Helium +116.83%
#2 MowCat MowCat +103.58%
#3 Seeker Seeker +97.95%
#4 Pons Pons +54.26%
#5 AI XOVIA AI XOVIA +49.74%
#6 UnifAI Network UnifAI Network +29.60%
#7 Bounce Bounce +27.22%
#8 pipedog pipedog +23.55%
#9 Zylo Ecosystem Zylo Ecosystem +21.30%
#10 TENDIES TENDIES +20.58%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Rank in Stocks #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Share Price
$8.92
Last synced: 2024-10-18
Market Cap
$674.03M
Change (1 day)
-5.14%
Change (1 year)
0.00%
Country
KR
Trade Jeisys Medical Inc. (287410)

Category

Healthcare
Revenue for Jeisys Medical Inc. (287410)
Revenue in Jun 2024 TTM: $121.50M
According to Jeisys Medical Inc. latest financial reports the company's current revenue (TTM) is $121.50M. In 2022 the company made a revenue of $92.36M an increase over the revenue in the year 2021 that was $68.38M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Jeisys Medical Inc. from 2020 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $121.50M 9.97%
2023 $110.49M 19.63%
2022 $92.36M 35.07%
2021 $68.38M 55.21%
2020 $44.06M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 38,242.06%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 21,165.30%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 29,105.32%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 17,180.88%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE